X4 Pharmaceuticals announced its participation in three key healthcare investment conferences in November 2026: Guggenheim, Stifel, and Jefferies. The company will present updates on its innovative therapies for rare hematology diseases, including its approved drug XOLREMDI® for WHIM syndrome and ongoing Phase 3 trials for chronic neutropenia. These events provide X4 an opportunity to engage with investors and highlight its progress and market potential. Live webcasts will be available on X4's website.
X4 Pharmaceuticals is the subject, with this data providing market context. For readers following healthcare stocks, 92 of 150 US health-sector stocks rose while 55 fell as of Nov 04, 2026 04:11 WIB. Notable movers include TXG at USD 65.43 (+6.17%), BTSG at USD 69.88 (+5.46%), and BAX at USD 24.23 (+5.35%).
Vencora has acquired CT InsureTech, a leading insurance technology provider with offices in London, Buenos Aires, and Mexico City. This acquisition strengthens Vencora's insurance technology offerings and expands its presence in Latin America and Eur...
Vencora has acquired CT InsureTech, a leading provider of insurance technology and services with offices in London, Buenos Aires, and Mexico City. This acquisition expands Vencora's portfolio and presence in Latin America and the UK, strengthening it...
JELD-WEN Holding, Inc. reported a net loss of $17.2 million in Q3 2026, a significant improvement from a $367.6 million loss a year earlier, driven by tariff refunds, productivity gains, and cost reductions. Net revenues slightly declined by 1.4% to ...
Ethereum has achieved end-to-end formal verification of leanVM, a minimal zero-knowledge virtual machine designed to aggregate post-quantum signatures efficiently. This milestone is part of Ethereum's plan to transition its network to quantum-resista...
Viking Therapeutics, a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced its participation in several major healthcare conferences from November to December 2026. The company will engage in fireside chat...
